Envejecimiento saludable en la mujer
CARMEN
University of Pittsburgh School of Medicine
Pittsburgh, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Pittsburgh School of Medicine (3)
2023
-
Corrigendum to “Evaluation of the impact, treatment patterns, and patient and physician perceptions of vasomotor symptoms associated with menopause in Europe and the United States” [Maturitas 164 (October 2022) 38–45] (Maturitas (2022) 164 (38–45), (S0378512222001360), (10.1016/j.maturitas.2022.06.008))
Maturitas
-
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study
The Lancet, Vol. 401, Núm. 10382, pp. 1091-1102